A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Surgery That Results in Removal of Both Ovaries.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 04 Aug 2015 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified April 2010).
- 11 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.